Expand BIIB Menu
BIIB MENU

BIIB Stock Posts


Unusual Option Volume

BIIB Biogen251.25-0.40 (-0.2%)

Biogen trades 5,091 contracts. The company has the following event: 19th Clinical Trials on Alzheimer's Disease Conference on Nov 17, 2026. News: The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of publicly-traded Biogen Inc. common stock- BIIB
Unusual Option Volume

BIIB Biogen252.17-2.70 (-1.1%)

Biogen trades 2,426 contracts. The company has the following event: ACR Convergence between Nov 6, 2026 and Nov 11, 2026. News: ACR 2026: Dapirolizumab Pegol Associated with Greater Treatment Response Rates Versus Placebo in SLE Using Novel Treatment Response Measure
Unusual Option Volume

BIIB Biogen257.89+8.24 (+3.3%)

Biogen trades 629 contracts. The company has the following event: 19th Clinical Trials on Alzheimer's Disease Conference on Nov 16, 2026. News: Stoke Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Updates
Unusual Option Volume

BIIB Biogen251.90+7.85 (+3.2%)

Biogen trades 1,263 contracts. The company has the following event: 19th Clinical Trials on Alzheimer's Disease Conference on Nov 16, 2026. News: Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026
Unusual Option Volume

BIIB Biogen258.30+5.57 (+2.2%)

Biogen trades 2,826 contracts. BIIB announced earnings today before the market opened.
Unusual Option Volume

BIIB Biogen249.99-0.70 (-0.3%)

Biogen trades 1,913 contracts. BIIB will report earnings on Oct 28, 2026.
Market Data Delayed 15 Minutes